Empowering People to be Ambassadors of their Own Health Since 1997.


Weekly News

Weekly news updates are currently posted on the Internet site and sent out via e-blast to provide up-to-date information on what has been covered in the news regarding hepatitis C in the previous week.  Topics include all stories related to hepatitis C  as well as personal stories and events.

HCV News

Week Ending 08/24/2015

While Washington Tackles Opioid Abuse Epidemic, Hepatitis C Treatment Remains Unaffordable

‘Big names in Washington are increasingly joining the fight to combat the rise of opioid and heroin abuse, but the conversation around the issue is missing half the problem. On Monday, the White House announced an initiative to curb heroin use by addressing it as both a public-safety and public-health issue, pairing law enforcement with access to treatment for addicts.’

FDA Approves Daklinza As New Treatment For Chronic Hepatitis C Genotype 3 Infections

‘The U.S. Food and Drug Administration has approved Bristol-Myers Squibb’s product Daklinza (daclatasvir) for treatment of hepatitis C virus (HCV) genotype 3 infections. Daklinza is the first drug that has demonstrated safety and efficacy to treat genotype 3 HCV infections without requiring co-administration of interferon or ribavirin, two older FDA-approved drugs also used to treat HCV infection.’

When to Start HCV Treatment: The Intersection of Guidelines and Real-World Practice

‘Treatment for hepatitis C virus (HCV) infection is changing at a pace almost too rapid for the average physician to keep up with. Until recently, HCV treatment required weekly interferon injections plus oral ribavirin for up to a year and was effective in only about half of patients with genotype 1.’

Hepatitis C Research Gets the Boost It Needed

‘Researchers have struggled to grow the hepatitis C virus (HCV) in a clinical lab setting since its discovery in 1989. However, a recent discovery about HCV genetics may have just changed that. Since HCV has not been able to be sufficiently replicated in a lab, understanding of the virus and development of treatments have taken a hit.’

Illinois governor vetoes bill to mandate hepatitis C testing

‘Illinois Gov. Bruce Rauner has vetoed legislation aimed at fighting an epidemic of contagious liver disease, saying it would cost the state money it doesn’t have. The legislation required doctors to offer hepatitis C tests to patients born between 1945 and 1965. The U.S. Centers for Disease Control and Prevention has recommended the tests since 2012.’

Bad News for Hepatitis C Patients: Your Treatment Costs May Be Higher Than Expected

‘When it comes to the world’s most pervasive infectious diseases, hepatitis C finds itself near the top of the list. According to estimates from the World Health Organization, some 180 million people worldwide have the hepatitis C virus, or HCV, many of whom aren’t aware of it. Within the United States, the Centers for Disease Control and Prevention has estimated that there are about 3.2 million HCV-positive patients.’

HCV Patients’ Medical Costs Four Times Those of People Without HCV

‘Average incremental costs associated with caring for hepatitis C virus (HCV) patients with commercial insurance are about four times higher than for those without the condition, and drug costs alone do not explain this variation, according to a new study from Milliman, an international actuarial consultant, commissioned by Primrose Healthcare.’

Caring Ambassadors Program, Inc. | P.O. Box 1748 | Oregon City, OR 97045 | 503-632-9032 | 503-632-9038 (Fax)